Antiproliferative Effect of 24‐Deoxysericoside From Terminalia macroptera Guill. & Perr. (Combretaceae) Against Breast Carcinoma: In Vitro, Molecular Docking and ADME Assessment
Key Points
To investigate the antiproliferative effects of 24‐deoxysericoside from Terminalia macroptera against breast carcinoma cells.
Isolated compounds were tested for their effects on cancer cell growth.
Molecular docking was performed to assess binding interactions.
ADME (Absorption, Distribution, Metabolism, Excretion) properties were evaluated.
The compound exhibits significant antiproliferative activity in vitro.
Molecular docking reveals strong binding affinity to cancer-related targets.
ADME assessment indicates favorable properties for therapeutic use.
Abstract
The studies showed that the isolated compounds could be used for the development of anticancer therapies.
Antiproliferative Effect of 24‐Deoxysericoside From Terminalia macroptera Guill. & Perr. (Combretaceae) Against Breast Carcinoma: In Vitro, Molecular Docking and ADME Assessment | Synapse